1. Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
2. Department of Clinical Research, Hematology, Lazzaro Spallanzani National Institute for Infectious Diseases, Rome, Italy; and
3. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX